Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Recruiting

Back to High-Risk Non-Muscle-Invasive Bladder Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(65 sites)

United States

Mayo Clinic Arizona, Phoenix, Arizona

Arizona Urology Specialty, Tucson, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Arkansas Urology, Little Rock, Arkansas

Michael G Oefelein, MD Clinical Trials, Bakersfield, California

Genesis Research (Greater Los Angeles), Los Alamitos, California

Advanced Urology, Los Angeles, California

Urology Center of Southern California, Murrieta, California

University of California, Irvine, Orange, California

Om research, San Diego, California

University of Southern California, San Diego, California

Genesis Research (Greater Los Angeles), Torrance, California

Colorado Urology, Lakewood, Colorado

Urology Associates, Lone Tree, Lone Tree, Colorado

University of Florida, Gainesville, Florida

Mayo Clinic Florida, Jacksonville, Florida

Advanced Urology Institute (Solaris), Largo, Florida

Advanced Urology Institute, Oxford, Florida

Advanced Urology Institute - Tallahassee (Solaris), Tallahassee, Florida

Emory University, Atlanta, Georgia

Associated Urological Specialists, Chicago Ridge, Illinois

Uropartners, Glenview, Illinois

Urology of Indiana - Carmel, Carmel, Indiana

Urology of Indiana, LLC (US Urology Partners), Greenwood, Indiana

First Urology, PSC, Jeffersonville, Indiana

Urologic Specialists of Northwest Indiana (Solaris), Merrillville, Indiana

Urology Center of Iowa Research, Clive, Iowa

Wichita Urology Group, Wichita, Kansas

Southern Urology (Urology America), Lafayette, Louisiana

Ochsner Medical Center, New Orleans, Louisiana

Anne Arundel Urology, Annapolis, Maryland

Chesapeake Urology Research Associates, Hanover, Maryland

Comprehensive Urology, Royal Oak, Michigan

Michigan Institute of Urology (Solaris), Troy, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Minnesota Urology, Woodbury, Minnesota

Specialty Clinical Research of St. Louis, St Louis, Missouri

Adult and Adolescent Urology, Omaha, Nebraska

Integrated Medical Professionals, PLLC (Solaris), New York, New York

University of Rochester, Rochester, New York

SUNY Upstate, Syracuse, New York

Associated Medical Professionals of NY, PLLC (US Urology Partners), Syracuse, New York

Montefiore Medical Center, The Bronx, New York

The Urology Group (Solaris), Cincinnati, Ohio

University of Cincinnati Cancer Center, Cincinnati, Ohio

Central Ohio Urology Group (US Urology Partners), Gahanna, Ohio

Oregon Urology Institute, Springfield, Oregon

Midlantic Urology (Solaris), Bala-Cynwyd, Pennsylvania

Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania

Keystone Urology Specialists, Lancaster, Pennsylvania

University of Pennsylvania, Philadelphia, Pennsylvania

Charleston Area Medical Center, Charleston, South Carolina

Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina

Lowcountry Urology (Solaris), North Charleston, South Carolina

The Conrad Pearson Clinic (Urology America), Germantown, Tennessee

Urology Associates, PC, Nashville, Tennessee

Amarillo Urology Research, Amarillo, Texas

UPNT Research Institute, LLC, Arlington, Texas

Urology Austin, PLLC (Urology America), Austin, Texas

Urology Clinics of North Texas, PLLC, Dallas, Texas

UT Southwestern Medical Center, Dallas, Texas

Houston Methodist, Houston, Texas

Urology San Antonio, PA dba USA Clinical Trials, San Antonio, Texas

Urology of Virginia, Virginia Beach, Virginia

Spokane Urology, Spokane, Washington